← Back to patent-cliff list

CAS 2150-37-0

methyl 3,5-dimethoxybenzoate

Codes: BENV-002, Resveratrol-001

Application context (from source-drug indications)

Plaque psoriasisBenvitimodAtopic dermatitisBenvitimodPsoriasisBenvitimodCutaneous T-cell lymphomaBenvitimodMycosis fungoidesBenvitimodMeleda diseaseBenvitimodDyslipidaemiaResveratrolPeripheral arterial diseaseResveratrolParkinson's diseaseResveratrol口腔扁平苔藓Resveratrol口腔疾病ResveratrolDiabetic neuropathyResveratrol

Source drugs (routes using this intermediate)

DrugTierExpiry
BenvitimodTier C — Watch / trade-
ResveratrolTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.